Amino Acid Hepatotoxicity Biomarkers in Human Hepatic Organoids: Promising Standardization of Drug Toxicity Evaluation
ACS Pharmacology & Translational Science · 14.02.2025 · 8 (2) · 510-521
DOI: 10.1021/acsptsci.4c00612 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 04.01.2025. Verfasst von Haneul Noh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Predictive Toxicology, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Trade, Industry and Energy, Korea Research Institute of Standards and Science.
Abstract (Originalsprache)
Human hepatic organoids (hHOs) are regarded as physiologically relevant in vitro platforms to evaluate hepatotoxicity, a critical step in drug development, but their applications are currently limited by the lack of qualified and standardized evaluation markers. In this study, by leveraging the established reference measurement system of amino acids (AAs), we propose 12 new biomarkers for drug-induced hepatotoxicity evaluation in human induced pluripotent stem cell-derived hHOs. Two orthogonal analytical methods for AAs were developed and validated based on isotope dilution mass spectrometry. Four AAs (aspartic acid, arginine, glutamine, and phenylalanine) and eight ratios of two designated AAs in the media of hHOs showed reliable alteration by drug treatment, which was confirmed by differentiating between hepatotoxic and nonhepatotoxic drugs. The superiorities of AA-based toxicity evaluation using the media of hHOs are as follows: (i) ability to use media only, without direct damage to or consumption of the organoids, (ii) ability to measure and compare quantities of AAs through a standardized reference measurement system rather than nonstandardized cell viability indicators, and (iii) no requirement for further data normalization in the case of the AA ratios. The AA analysis-based results demonstrate the reliability and potential of the proposed biomarkers as not only straightforward indicators of drug-induced hepatotoxicity but also absolutely comparable measures as a step toward standardization based on the AA reference measurement system.
Autor:innen und Institutionen
- Department of Predictive Toxicology, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea.
- Korea Research Institute of Standards and Science, 267 Gajeong-ro, Yuseong-gu, Daejeon 34113, Republic of Korea.
- University of Science and Technology, 217 Gajeong-ro, Yuseong-gu, Daejeon 34113, Republic of Korea.
- School of Earth Sciences and Environmental Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea.
ORCID-Profile: Ha-Jeong Kwon, Tae-Young Kim, Ji-Seon Jeong
Förderung
- Ministry of Trade, Industry and Energy
- Korea Research Institute of Standards and Science
Zitieren
APA
Noh, H., Choi, S., Park, K. W., Lee, S., Seok, D. W., Kim, Y. E., Kwon, H. J., Kim, H., Park, H. J., Kim, T. Y., Kang, D., & Jeong, J. S. (2025). Amino Acid Hepatotoxicity Biomarkers in Human Hepatic Organoids: Promising Standardization of Drug Toxicity Evaluation. ACS Pharmacology & Translational Science, 8(2), 510-521. https://doi.org/10.1021/acsptsci.4c00612
Vancouver
Noh H, Choi S, Park KW, Lee S, Seok DW, Kim YE, et al. Amino Acid Hepatotoxicity Biomarkers in Human Hepatic Organoids: Promising Standardization of Drug Toxicity Evaluation. ACS Pharmacology & Translational Science. 2025;8(2):510-521. doi:10.1021/acsptsci.4c00612
BibTeX
@article{Noh2025,
author = {Noh, Haneul and Choi, Seohyun and Park, Kyung Won and Lee, Shinji and Seok, Dong Wook and Kim, Young Eun and Kwon, Ha-Jeong and Kim, Hyemin and Park, Han-Jin and Kim, Tae-Young and Kang, Dukjin and Jeong, Ji-Seon},
title = {Amino Acid Hepatotoxicity Biomarkers in Human Hepatic Organoids: Promising Standardization of Drug Toxicity Evaluation},
journal = {ACS Pharmacology & Translational Science},
year = {2025},
volume = {8},
number = {2},
pages = {510--521},
doi = {10.1021/acsptsci.4c00612}
}
EUVIMED